AdaptHealth Corp (NAS:AHCO)

$ 9.76 -0.29 (-2.89%) Market Cap: 1.35 Bil Enterprise Value: 3.44 Bil PE Ratio: 0 PB Ratio: 0.89 GF Score: 63/100

Q3 2024 Adapthealth Corp Earnings Call Transcript
Nov 05, 2024

$9.18 (-9.56%)

Earnings
Q2 2024 Adapthealth Corp Earnings Call Transcript
Aug 06, 2024

$8.66 (-21.06%)

Earnings
Q1 2024 Adapthealth Corp Earnings Call Transcript
May 07, 2024

$9.76 (-7.92%)

Earnings
Q4 2023 Adapthealth Corp Earnings Call Transcript
Feb 27, 2024

$10 (+31.06%)

Earnings
Adapthealth Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2024
Adapthealth Corp at Bank of America Home Care Conference (Virtual) Transcript
Dec 05, 2023
Q3 2023 Adapthealth Corp Earnings Call Transcript
Nov 07, 2023

$7.69 (-8.99%)

Earnings
Adapthealth Corp at Canaccord Genuity Growth Conference Transcript
Aug 09, 2023
Q2 2023 Adapthealth Corp Earnings Call Transcript
Aug 08, 2023

$14.68 (+10.38%)

Earnings
Adapthealth Corp at RBC Capital Markets Global Healthcare Conference Transcript
May 16, 2023
Q1 2023 Adapthealth Corp Earnings Call Transcript
May 09, 2023

$11.3 (-6.38%)

Earnings
Q4 2022 Adapthealth Corp Earnings Call Transcript
Feb 28, 2023

$15.99 (-27.25%)

Earnings
Adapthealth Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Adapthealth Corp at Bank of America Securities Home Care Conference (Virtual) Transcript
Dec 05, 2022
Q3 2022 Adapthealth Corp Earnings Call Transcript
Nov 08, 2022

$20.61 (-2.14%)

Earnings
Adapthealth Corp Capital Markets Day Transcript
Sep 16, 2022
Q2 2022 Adapthealth Corp Earnings Call Transcript
Aug 09, 2022

$22.24 (-13.53%)

Earnings
Adapthealth Corp at Jefferies Healthcare Conference Transcript
Jun 08, 2022
Adapthealth Corp at UBS Global Healthcare Conference Transcript
May 25, 2022
Adapthealth Corp at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2022
Adapthealth Corp at Bank of America Healthcare Conference Transcript
May 11, 2022
Q1 2022 Adapthealth Corp Earnings Call Transcript
May 10, 2022

$14.86 (+30.01%)

Earnings
Q4 2021 Adapthealth Corp Earnings Call Transcript
Feb 24, 2022

$15.19 (-2.38%)

Earnings
Q3 2021 Adapthealth Corp Earnings Call Transcript
Nov 04, 2021

$25.85 (-1.93%)

Earnings
Adapthealth Corp at Deutsche Bank Leveraged Finance Conference (Virtual) Transcript
Oct 06, 2021
Q2 2021 Adapthealth Corp Earnings Call Transcript
Aug 05, 2021

$25.13 (+15.75%)

Earnings
Adapthealth Corp at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021
Adapthealth Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 12, 2021
Q1 2021 Adapthealth Corp Earnings Call Transcript
May 06, 2021

$25.41 (-11.77%)

Earnings
Q4 2020 Adapthealth Corp Earnings Call Transcript
Mar 04, 2021

$31.08 (+1.94%)

Earnings
Adapthealth Corp at JPMorgan Global High Yield & Leveraged Finance Conference (Virtual) Transcript
Mar 03, 2021
Adapthealth Corp Special Shareholders Meeting Transcript
Mar 03, 2021
Adapthealth Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 14, 2021
Q3 2020 Adapthealth Corp Earnings Call Transcript
Nov 04, 2020

$29.29 (+0.17%)

Earnings
Adapthealth Corp at Canaccord Genuity Growth Conference (Virtual) Transcript
Aug 13, 2020
Adapthealth Corp Annual Shareholders Meeting Transcript
Jul 09, 2020
Adapthealth Corp to Acquire Solara Medical Supplies LLC and Activstyle Inc Conference Call Transcript
May 26, 2020
Adapthealth Corp at RBC Global Healthcare Conference (Virtual) Transcript
May 20, 2020

Q3 2022 Adapthealth Corp Earnings Call Transcript

Nov 08, 2022 / 01:30PM GMT

Release Date Price: $20.61 (-2.14%)

Transcript 10-Q8-K

Operator

Greetings, and welcome to AdaptHealth's Third Quarter 2022 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Chris Joyce, General Counsel. Thank you. You may begin.

Christopher J. Joyce

AdaptHealth Corp. - General Counsel & Secretary

Thank you, operator. I'd like to welcome everyone to today's AdaptHealth Corp. conference call for the third quarter ended September 30, 2022. Everyone should have received a copy of our earnings release earlier this morning. If not, I'd like to highlight that the earnings release as well as the supplemental slide presentation regarding Q3 2022 results is posted on the Investor Relations section of our website.

In a moment, we'll have some prepared comments from Steve Griggs, Chief Executive Officer of AdaptHealth; Josh Parnes, President of AdaptHealth; and Jason Clemens, Chief Financial Officer of AdaptHealth. We will then open the call for questions.

Before we begin, I'd like to remind

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.